fashion -WSS

fashion

author：comprehensive 2025-08-23 08:54:31 - browse：783

Drugmakers already bet big on mRNA for cancer. Now President Biden is going in, too? Anna Moneymaker/Getty Images

WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine — and one where the drug industry has a multibillion-dollar head start.

The White House announced Wednesday that the Advanced Research Projects Agency for Health would bankroll a $24 million project by Emory University to build messenger RNA platforms to target “cancer and other diseases,” investing in the technology behind the U.S.’s most commonly used vaccines for Covid-19.

The administration touted the news of CUREIT as the latest in Biden’s longtime mission to rein in cancer deaths, the Cancer Moonshot. But by using mRNA to treat cancer, ARPA-H is wading into a field that has advanced in fits and starts — and whose industry leaders have already spent multiples of the program’s entire budget into their own research. Moderna and BioNTech, massively profitable companies that have sold more than $80 billion worth of Covid-19 vaccines combined, have singled out oncology as the next big application for mRNA and invested accordingly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Women's World Cup brings attention to abuse in soccer

hotspot

WSS

TikTok cracks down on users posting about weight loss drugs

Trump got a 'target letter.' What is one and what does it mean?

Antibody drugs appear effective. Now can we make enough of them?

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Medical experts are missing from AI regulatory conversations

How dance can help health care workers heal from trauma

leisure time

fashion

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Duchenne breakthrough therapy leaves behind pioneering families

Researchers separate signal from noise in heart wearable data

Guidelines to prevent youth baseball injuries need more muscle

Trump got a 'target letter.' What is one and what does it mean?

Affirmative action in medical school literally saved lives

Grail's uphill battle for Medicare to cover its cancer screening test

Moonlake's readout produced a cash windfall. Risks remain

Trump got a 'target letter.' What is one and what does it mean?

focus

Britney Spears to release memoir, 'The Woman In Me,' later this year

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

States increasingly look to regulate hospital facility fees

One Duchenne patient's bittersweet hope for new treatment

Norman Reedus' Daryl Dixon

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

knowledge

hotspot

hotspot

leisure time